MPM BioVentures 2014 reports Entrada Therapeutics share disposal worth $1.89 million
Reuters2026/09/09 23:24- MPM BioVentures 2014 reported sales of 259,837 Entrada Therapeutics common shares from Sep. 4-9.
- Weighted-average sale prices were $7.11, $7.41, $7.13.
- Indirect beneficial ownership fell to 3,885,115 shares following the latest sale.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Goldman Sachs evaluates Apple's foldable iPhone: Pricing is “affordable,” with shipments this year reaching up to 35 million units
A Goldman Sachs report indicates that iPhone Duo, with its "thinnest ever" design and "affordable" pricing, is expected to open up the mass market. The forecast for 2026 remains at 14 to 35 million units shipped. The new product's upgrades in hinges, cooling, and camera technologies will benefit the supply chain in Greater China, including Foxconn.
Edyoutec partners with Skiply to sell 10Monkeys subscriptions in UAE from Sept. 15
Nissan reorganizes Japan manufacturing footprint, shifts vehicle production among plants
Crypto prices
More
